GENB
Generate Biomedicines, Inc.
15.20$
-5.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| -575.5% | -629.0% | |
| 75.0% | 41.3% | |
| 95.1% | 64.5% | |
| 137.4% | -45.8% | |
| 16.8% | 11.0% | |
| -282.1% | 366.1% | |
| -54.4% | -25.6% | |
| 446.4% | 88.0% | |
| -411.3% | -174.9% | |
| -592.4% | -640.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.